Baxter International
OverviewSuggest Edit
Baxter International is a provider of critical care, nutrition, renal, hospital, and surgical products. The company offers acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, and surgical hemostat and sealant products. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and by patients at home under physician supervision.
| Type | Public | |
| Founded | 1931 | |
| HQ | Deerfield, IL, US | Map |
| Website | baxter.com | |
| Employee Ratings | More | |
| Overall Culture | D+ | More |
Recent NewsAll News
- Worldwide Intravenous Solutions Industry to 2027 - Featuring Ajinomoto, Baxter International and Grifols Among Others
- Sell health-care stock Baxter International as headwinds mount, Goldman says
- Global Dialysis Market to 2030 - Featuring Baxter International, Nikkiso and Asahi Kasei Among Others
- Small Bore Connectors Market is Set to Grow by USD 147.18 million from 2021 to 2026 | Evolving Opportunities with B. Braun Melsungen AG & Baxter International Inc. | Technavio
Key People/Management at Baxter International
Jose E. Almeida
Catherine R Smith
Stacey Eisen
Giuseppe Accogli
James Borzi
Cristiano Franzi
Baxter International Office Locations
Baxter International Financials and Metrics
Baxter International Revenue
| USD | |
|---|---|
Revenue (Q2, 2021) | 3.1b |
Gross profit (Q2, 2021) | 1.2b |
Gross profit margin (Q2, 2021), % | 39.8% |
Net income (Q2, 2021) | 301.0m |
EBIT (Q2, 2021) | 424.0m |
Market capitalization (4-May-2022) | 36.7b |
Closing stock price (4-May-2022) | 73.2 |
Cash (30-Jun-2021) | 3.1b |
EV | 40.2b |
| USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 |
|---|---|---|---|---|---|---|---|---|
Net Income | 347.0m | 690.0m | 1.0b | 333.0m | 580.0m | 939.0m | 300.0m | 601.0m |
Depreciation and Amortization | 195.0m | 393.0m | 580.0m | 199.0m | 401.0m | 610.0m | 217.0m | 439.0m |
Inventories | (82.0m) | (91.0m) | (88.0m) | (83.0m) | (261.0m) | (305.0m) | (129.0m) | (155.0m) |
Accounts Payable | (310.0m) | (308.0m) | (249.0m) | (110.0m) | (48.0m) | 36.0m | 22.0m | (9.0m) |
| USD | FY, 2018 |
|---|---|
Revenue/Employee | 222.5k |
Debt/Equity | 0.4 x |
Debt/Assets | 0.2 x |
Financial Leverage | 2 x |
Baxter International Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Hillrom | December 13, 2021 | |
| Cheetah Medical | September 10, 2019 | $230 m |
| ApaTech Limited | ||
| Baxter AO | ||
| Baxter Belgium SPRL | ||
| Baxter (China) Investment Co., Ltd | ||
| Baxter Company Ltd | ||
| Baxter Corporation (Canada) | ||
| Baxter Corporation Englewood | ||
| Baxter de Guatemala, Sociedad Anonima |
Baxter International Revenue Breakdown
Baxter International revenue breakdown by business segment: 6.3% from Acute Therapies, 18.2% from Pharmaceuticals, 32.2% from Renal Care, 23.4% from Medication Delivery, 7.9% from Clinical Nutrition, 7.6% from Advanced Surgery and 4.4% from Other
Baxter International revenue breakdown by geographic segment: 26.8% from EMEA, 21.2% from APAC and 52.0% from Americas
Baxter International Cybersecurity Score
Baxter International Environment, Social & Governance (ESG) Ratings
Baxter International Online and Social Media Presence
15.52k Twitter followers
Baxter International has 15.52k Twitter Followers. The number of followers has increased 0.5% month over month and increased 0.9% quarter over quarter
Baxter International's Trends
Twitter Engagement Stats for @baxter_intl
2k
Tweets
2
Following
15.5k
Followers
12
Tweets last 30 days
8.2
Avg. likes per Tweet
100%
Tweets with engagement
Baxter International Company Culture
Overall Culture
D+
64/100
CEO Rating
D+
65/100
Compensation
C+
71/100
Diversity
D-
57/100
Baxter International News and Updates
Worldwide Intravenous Solutions Industry to 2027 - Featuring Ajinomoto, Baxter International and Grifols Among Others
Sell health-care stock Baxter International as headwinds mount, Goldman says
Global Dialysis Market to 2030 - Featuring Baxter International, Nikkiso and Asahi Kasei Among Others
Small Bore Connectors Market is Set to Grow by USD 147.18 million from 2021 to 2026 | Evolving Opportunities with B. Braun Melsungen AG & Baxter International Inc. | Technavio
United States Anesthesia Drugs Market Report 2022-2027 Featuring Baxter International, Abbvie, Endo International, Draegerwerk, and Koninklijke Philips
Worldwide IV Bottles Industry to 2031 - Featuring Baxter International, Vioser and JW Lifescience Among Others
Baxter International Blogs
Uniting to Save and Sustain Lives
Baxter International Frequently Asked Questions
When was Baxter International founded?
Baxter International was founded in 1931.
Who are Baxter International key executives?
Baxter International's key executives are Jose E. Almeida, Catherine R Smith and Stacey Eisen.
How many employees does Baxter International have?
Baxter International has 50,000 employees.
What is Baxter International revenue?
Latest Baxter International annual revenue is $11.7 b.
What is Baxter International revenue per employee?
Latest Baxter International revenue per employee is $233.5 k.
Who are Baxter International competitors?
Competitors of Baxter International include Boston Scientific, Abbott and Becton Dickinson.
Where is Baxter International headquarters?
Baxter International headquarters is located at 1 Baxter Pkwy, Deerfield.
Where are Baxter International offices?
Baxter International has offices in Deerfield, Marion, Opelika, Round Lake and in 64 other locations.
How many offices does Baxter International have?
Baxter International has 73 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies